MC38-hCD47-hCLDN18.2-hEGFR
品系基本信息
*使用本品系发表的文献需注明: MC38-hCD47-hCLDN18.2-hEGFR cell line (Cat. NO. NM-S13-TM73) was purchased from Shanghai Model Organisms Center, Inc..
验证数据
Fig.1 hCD47, hCLAUDIN18.2 and hEGFR expression in MC38-hCD47/hCLAUDIN18.2/hEGFR cell line
Fig.2 Tumor growth curve of MC38-hCD47/hCLAUDIN18.2/hEGFR syngeneic model
Fig.3 Body weight change of MC38-hCD47/hCLAUDIN18.2/hEGFR syngeneic model
Fig.4 The expression of hCD47, hCLAUDIN18.2 and hEGFR in humanized modified tumors by FACS
你也可能感兴趣
Tamoxifen诱导Cre-ERT2小鼠 使用指南
Cre-ERT2在无Tamoxifen诱导的情况下，在细胞质内处于无活性状态；当Tamoxifen诱导后，Tamoxifen的代谢产物4-OHT（雌激素类似物）与ERT结合，可使Cre-ERT2进核发挥Cre重组酶活性。
查看
